| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00210-009-0452-6 |
| P698 | PubMed publication ID | 19760273 |
| P50 | author | Dobromir Dobrev | Q110902296 |
| P2093 | author name string | Klaus Matschke | |
| Niels Voigt | |||
| Ursula Ravens | |||
| Erich Wettwer | |||
| Torsten Christ | |||
| Anne Trausch | |||
| Nadiia Rozmaritsa | |||
| Thomasz Zimniak | |||
| P2860 | cites work | ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation | Q22306351 |
| Effect of dronedarone on cardiovascular events in atrial fibrillation | Q28235128 | ||
| Distribution of the muscarinic K+ channel proteins Kir3.1 and Kir3.4 in the ventricle, atrium, and sinoatrial node of heart | Q28570285 | ||
| Ionic determinants of functional reentry in a 2-D model of human atrial cells during simulated chronic atrial fibrillation | Q30476498 | ||
| Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels. | Q33206302 | ||
| The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation | Q34473254 | ||
| New ideas about atrial fibrillation 50 years on. | Q34503407 | ||
| Remodeling of cardiomyocyte ion channels in human atrial fibrillation | Q35186203 | ||
| Antiarrhythmic agents act differently on the activation phase of the ACh-response in guinea-pig atrial myocytes | Q35870948 | ||
| Mechanisms of the anticholinergic effect of SUN 1165 in comparison with flecainide, disopyramide and quinidine in single atrial myocytes isolated from guinea-pig | Q35872647 | ||
| JPCalc, a software package for calculating liquid junction potential corrections in patch-clamp, intracellular, epithelial and bilayer measurements and for correcting junction potential measurements | Q36750848 | ||
| Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods | Q36801449 | ||
| Pathology-specific effects of the IKur/Ito/IK,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation | Q36842497 | ||
| New concepts in understanding and modulating atrial repolarisation in patients with atrial fibrillation | Q37106294 | ||
| Inward rectifier potassium currents as a target for atrial fibrillation therapy | Q37231697 | ||
| Atrial remodeling and atrial fibrillation: mechanisms and implications. | Q37609710 | ||
| Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence | Q40310174 | ||
| Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study Group | Q42274536 | ||
| Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation | Q42509641 | ||
| The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation | Q43782709 | ||
| Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current (I(K,ACh) in chronic human atrial fibrillation: decrease in GIRK4 mRNA correlates with reduced I(K,ACh) and muscarinic receptor-mediated shortening of action poten | Q43803581 | ||
| Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation | Q44025889 | ||
| Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs. | Q44653099 | ||
| Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium | Q44799799 | ||
| Perspectives and limitations in the treatment of vagus-induced atrial fibrillation. Insights from cellular pharmacology | Q45025687 | ||
| Safety of the novel atrial-selective K+-channel blocker AVE0118 in experimental heart failure | Q46274903 | ||
| Changes in I K, ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes | Q46897896 | ||
| Plasma and tissue levels of flecainide in rats | Q48317019 | ||
| Block of delayed rectifier potassium current, IK, by flecainide and E-4031 in cat ventricular myocytes | Q68339880 | ||
| Plasma propafenone concentration in the evaluation of anti-arrhythmic efficacy | Q70221027 | ||
| Potassium channel blocking properties of propafenone in rabbit atrial myocytes | Q70602374 | ||
| Differential effects of the new class III agent dofetilide on potassium currents in guinea pig cardiomyocytes | Q71665817 | ||
| Inhibitory effects of dronedarone on muscarinic K+ current in guinea pig atrial cells | Q73298210 | ||
| Ionic mechanisms of electrical remodeling in human atrial fibrillation | Q73311823 | ||
| Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation | Q73381111 | ||
| G-Protein beta(3)-subunit 825T allele is associated with enhanced human atrial inward rectifier potassium currents | Q74131870 | ||
| Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat | Q80233954 | ||
| Kir3-based inward rectifier potassium current: potential role in atrial tachycardia remodeling effects on atrial repolarization and arrhythmias | Q83058608 | ||
| P433 | issue | 3 | |
| P921 | main subject | atrial fibrillation | Q815819 |
| P304 | page(s) | 251-259 | |
| P577 | publication date | 2009-09-17 | |
| P1433 | published in | Naunyn-Schmiedeberg's Archives of Pharmacology | Q1468251 |
| P1476 | title | Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation | |
| P478 | volume | 381 |
| Q38111636 | Atrial selectivity of antiarrhythmic drugs |
| Q37809985 | Atrial-selective drugs for treatment of atrial fibrillation |
| Q84032438 | Atrial-selective sodium channel block by dronedarone: sufficient to terminate atrial fibrillation? |
| Q27027326 | Calcium dysregulation in atrial fibrillation: the role of CaMKII |
| Q47254019 | Comparison of the effects of IK,ACh, IKr, and INa block in conscious dogs with atrial fibrillation and on action potentials in remodeled atrial trabeculae. |
| Q42436292 | Impaired Na⁺-dependent regulation of acetylcholine-activated inward-rectifier K⁺ current modulates action potential rate dependence in patients with chronic atrial fibrillation. |
| Q37063856 | Isolation of human atrial myocytes for simultaneous measurements of Ca2+ transients and membrane currents |
| Q26799483 | Methods for isolating atrial cells from large mammals and humans |
| Q47228722 | Muscarinic type-1 receptors contribute to IK,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation |
| Q24292961 | NOS1AP modulates intracellular Ca(2+) in cardiac myocytes and is up-regulated in dystrophic cardiomyopathy |
| Q38069201 | New directions in antiarrhythmic drug therapy for atrial fibrillation |
| Q48644420 | Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channels. |
| Q37998312 | Novel molecular targets for atrial fibrillation therapy |
| Q43191375 | Novel pharmacological approaches for antiarrhythmic therapy |
| Q37106753 | Pleiotropic effects of antiarrhythmic agents: dronedarone in the treatment of atrial fibrillation |
| Q38103541 | Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update |
| Q47433213 | Structural basis for the antiarrhythmic blockade of a potassium channel with a small molecule |
| Q36900723 | The GIRK1 subunit potentiates G protein activation of cardiac GIRK1/4 hetero-tetramers |
| Q37821928 | The pharmaceutical pipeline for atrial fibrillation |
| Q37799958 | The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications |
| Q47748973 | Voltage-gated and stretch-activated potassium channels in the human heart : Pathophysiological and clinical significance |
| Q50690847 | [New developments in the antiarrhythmic therapy of atrial fibrillation]. |
Search more.